drugset / Trial / NCT06471543
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN0361 in Adult healthy subjects and Adult Hypertriglyceridemic Subjects.
Timeline
- Start
- 2024-09-30
- Primary completion
- 2026-06-03
- Completion
- 2026-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RN0361 | Unknown | — | Subcutaneous |